HHTM

EDEN PRAIRIE, MINNESOTA – Starkey has announced that its Chief Audiology Officer and Executive Vice President of Product Strategy, Dr. Sara Burdak, has been named the Gold Winner for Woman of the Year in the manufacturing category of the Stevie Awards for Women in Business. This global award program recognizes women executives for their innovative initiatives and outstanding leadership. “Receiving this

This week, Brian Taylor sits down with Dr. Alison Huang, a senior research associate at the John Hopkins Bloomberg School of Public Health, to delve into the complex relationship between loneliness, social networks, and hearing loss. Dr. Huang shares her expertise as both an epidemiologist and a gerontologist, discussing the prevalence of social isolation and loneliness among older adults, particularly

Pathways, in collaboration with the University of Kentucky Department of Otolaryngology – Head and Neck Surgery, is pleased to announce a virtual mini-symposium focusing on Central Auditory Processing Disorder (CAPD) and Neuroaudiology. The event will take place on Saturday, April 27, 2024 This unique event brings together renowned clinicians and researchers to delve into contemporary topics in these specialized fields.

Click here to read the March 2024 NeuroAudiology Newsletter.

ISELIN, NEW JERSEY – Hearing aid manufacturer Rexton today unveiled Rexton Reach, an all-new hearing aid platform that is designed to enable wearers to actively engage in group conversations and discern multiple voices simultaneously, even amidst background noise. The initial hearing aid model utilizing the Rexton Reach platform is the Rexton Reach R-Li T, a rechargeable receiver-in-canal (RIC) model. “When

With hearing loss representing a growing yet vastly undertreated global health crisis, a new webinar looks to combat widespread misconceptions and stigma that discourage people from seeking help. The online event titled “Hearing Loss Misconceptions and Breaking Stigma” is being hosted by Tuned, a digital hearing health company providing preventive and comprehensive hearing health for employers. It will feature insights

MONTPELLIER, FRANCE — Biotechnology company Sensorion has announced that it has met the primary endpoint for its Phase 2a clinical trial of SENS-401, a drug candidate aimed at preserving residual hearing after cochlear implantation. The Phase 2a trial was a multicenter, randomized, controlled, open-label study designed to evaluate the presence of SENS-401 in the inner ear fluid (perilymph) at potentially

This week, host Bob Traynor welcomes Vanessa Gauthier-Davidson from Shoebox to discuss the evolution of online hearing screening and shed light on the development of Shoebox’s online screening tool. The discussion covers the development process, accuracy factors, and the customizable nature of Shoebox’s online screener. Vanessa discusses why an increasing number of clinics are implementing such screeners, highlighting their role

A team from Western University has utilized the bright light of the Canadian Light Source (CLS) at the University of Saskatchewan to obtain highly detailed images of the intricate structures in the inner ear. These images have enabled them to pioneer customized programming strategies for hearing implants. The cochlea, the spiral-shaped structure within the inner ear responsible for transmitting sound

PITTSBURGH, PENNSYLVANIA — A team of doctors and scientists from the University of Pittsburgh Medical Center (UPMC) and the University of Pittsburgh have developed a groundbreaking smartphone app that uses artificial intelligence (AI) to accurately diagnose ear infections, known as acute otitis media (AOM), in young children. Their findings, published in the journal JAMA Pediatrics, suggest that this AI tool